If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 10 of 18
A Clinical Evaluation of the RheOx Bronchial Rheoplasty System for the Treatment of the Symptoms of Chronic Bronchitis in Adult Patients with COPD
RheOx Bronchial Rheoplasty System for the Treatment of Symptoms of COPD
Protocol No
PULM-GALA-RHESOLVE
Categories
A Randomized Controlled Trial of an iPad for Patient Communication during Mechanical Ventilation
iPad for Patient Communication
Protocol No
PULM-IPAD
Categories
Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) and Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype Prospective Outcomes (IPF-PRO/ILD-PRO) Registry
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Protocol No
PULM-IPF-PRO
Categories
NaVigation Endoscopy to Reach Indeterminate lung nodules versus Transthoracic needle Aspiration, a randomized controlled Study (VERITAS)
Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration (VERITAS)
Protocol No
PULM-MEDTRONIC-VERITASTHO19102
Categories
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment With the Nuvaira Lung Denervation System in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Evaluation of the Safety and Efficacy of TLD in Patients With COPD
Protocol No
PULM-NUVAIRA-AIRFLOW-3
Categories
The Impact of Sarcopenic Obesity on Strength, Physical Functioning, and Pain Perception after Critical Illness
The Impact of Sarcopenic Obesity on Strength, Physical Functioning, and Pain Perception after Critical Illness
Protocol No
PULM-SOS-II
Categories
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON)
Protocol No
PULM-UNITED-TETON
Categories
A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD)
PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (ATHENA-SSc-ILD)
Protocol No
RHEU-PROMETHEUS-ATHENA
Categories
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Protocol No
PULM-VERACYTE-ENVISIA-ILD
Categories
A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)
Ralinepag in Subjects with PAH via an Open-label Extension
Protocol No
PULM-UNITED-ROR-PH-303
Categories